CLINICAL_TRIALS
trial_result
· 2021-03-03
Clinical Trial Update: Celebrex Total Knee Arthroplasty Study [Phase 4]
Summary
Phase 4 clinical trial update for Celebrex in total knee arthroplasty terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Osteoarthritis, Pain | Phase 4 | Status: TERMINATED